Viewing Study NCT00493766


Ignite Creation Date: 2025-12-24 @ 4:40 PM
Ignite Modification Date: 2026-02-21 @ 9:25 PM
Study NCT ID: NCT00493766
Status: TERMINATED
Last Update Posted: 2020-12-19
First Post: 2007-06-26
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Safety of LBH589 Alone and in Combination With IV Docetaxel and Prednisone
Sponsor: Novartis Pharmaceuticals
Organization:

Organization Data

Organization:
Class: INDUSTRY
Study ID: CLBH589B2105
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators